Common Side Effects: Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, dysgeusia, dyspepsia (predominate during titration)
(eds.), Sleep Disorders and sleep deprivation: An unmet public health problem
Indications for Semaglutide Semaglutide is indicated for chronic weight management in individuals with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related condition or in individuals with a BMI of 30 kg/m2 or greater
Empower ships injectable tirzepatide nationwide
Los pacientes deben informar a su mdico sobre cualquier efecto secundario persistente o que interfiera significativamente con su calidad de vida, ya que pueden ser necesarios ajustes en la dosis o el tratamiento